Across Global Alliance Implements Wemedoo's oomnia® for Enhanced Clinical Trial Infrastructure
Introduction
In an important development in the realm of clinical studies, the Across Global Alliance has partnered with Wemedoo AG to implement the advanced data management system, oomnia®, as its primary infrastructure. This strategic decision aims to streamline clinical trial management and enhance collaboration among the alliance's members operating in over 90 countries.
What is Across Global Alliance?
The Across Global Alliance is a strategic alliance that brings together various clinical research organizations (CROs) and specialized service providers. With a mission to improve the operational framework of clinical trials, the alliance focuses on delivering seamless and efficient research services across diverse therapy areas. By integrating local expertise with a standardized operational model, the alliance ensures comprehensive clinical research services.
The Choice for oomnia®
After a detailed evaluation of the existing solutions in the market, oomnia® was recognized as the only platform capable of addressing the complex operational requirements of the Alliance. This advanced system integrates essential clinical trial functionalities including Electronic Data Capture (EDC), Clinical Trial Management System (CTMS), Randomization and Trial Supply Management (RTSM), and electronic Trial Master File (eTMF) into a single, unified platform. By doing so, oomnia® helps eliminate inefficiencies arising from the use of fragmented systems and disjointed data workflows.
Benefits of Using oomnia®
The necessity for a robust system in conducting global clinical trials is paramount. Steven Bukvic, Chairman of the Across Global Alliance, emphasized that the implementation of oomnia® will facilitate seamless collaboration, prevent unnecessary delays, and ensure consistent data across all trial sites. This powerful platform is designed not only with compliance in mind but also with operational flexibility, which is critical for research organizations.
Enhanced Compliance
One of the most compelling advantages of utilizing oomnia® is its potential to enhance compliance with regulatory standards in over 90 countries. This compliance ensures that clinical trials adhere to the highest ethical and operational standards, a factor that is critical for the success of any clinical study.
Real-Time Data Quality Assurance
With oomnia® serving as the digital backbone for the Across Global Alliance, all members benefit from real-time data quality checks. This functionality is vital for maintaining high data integrity—allowing research teams to identify and address data issues as they arise, thereby reducing the risk of trial delays and inaccuracies.
A Step Towards Innovation
Nina Cihoric, CEO of Wemedoo AG, noted that this collaboration represents a significant shift in the management of clinical trials. By providing an integrated and adaptable system, Wemedoo enables Alliance members to concentrate on scientific advancements rather than administrative hurdles. This innovative approach redefines how clinical trials are conducted and managed, making it easier and more efficient for all stakeholders involved.
Conclusion
The selection of Wemedoo's oomnia® by the Across Global Alliance marks a pivotal moment in clinical research management. By addressing complex operational needs, enhancing compliance, and ensuring real-time data integrity, this partnership is poised to revolutionize the global clinical trial landscape. As the Alliance continues to grow, the implementation of such advanced infrastructure will undoubtedly result in more efficient, compliant, and successful clinical research initiatives worldwide.